Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
17
17 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- Bimatoprost Implant SystemPhase 33 trials
SpyGlass Pharma, Inc. · Cataract, Glaucoma, Ocular Hypertension
- Timolol eye drops 0.5%Phase 33 trials
Glaukos Corporation · Glaucoma, Ocular Hypertension
- Gen 2 Travoprost Intracameral ImplantGen 2 Travoprost Intraocular ImplantPhase 32 trials
Glaukos Corporation · Glaucoma
- Inactive controlQLS-111 vehiclePhase 32 trials
Can-Fite BioPharma · Hepatocellular Carcinoma, Cirrhosis, Open-angle Glaucoma (OAG)
- NCX 470NCX 470 0.1%Phase 32 trials
Nicox Ophthalmics, Inc. · Open Angle Glaucoma, Ocular Hypertension
- OPC-1085ELPhase 31 trial
Otsuka · Open Angle Glaucoma or Ocular Hypertension
- QLS-111Phase 23 trials
Qlaris Bio, Inc. · Normal Tension Glaucoma (NTG), Glaucoma, Open-angle Glaucoma (OAG)
- BL1107Phase 22 trials
Bausch & Lomb Incorporated · Dry Eye Disease, Glaucoma
- PER-001 Intravitreal ImplantPhase 22 trials
Perfuse Therapeutics, Inc. · Diabetic Retinopathy, Open-angle Glaucoma
- PER-001 Intravitreal Implant - ShamPhase 22 trials
Perfuse Therapeutics, Inc. · Diabetic Retinopathy, Open-angle Glaucoma
- AGN-193408Phase 21 trial
AbbVie · Open-angle Glaucoma, Ocular Hypertension
- AR-17043Phase 21 trial
Alcon Research · Open Angle Glaucoma, Ocular Hypertension
- ASP2767Phase 21 trial
Astellas · Glaucoma
- GVB-2001Phase 21 trial
IVIEW Therapeutics Inc. · Primary Open-Angle Glaucoma (POAG)
- intraocular implant releasing timololTimoD implantPhase 21 trial
EyeD Pharma · Glaucoma, Ocular Hypertension
- PG043Phase 21 trial
Alcon Research · Open Angle Glaucoma, Ocular Hypertension
- REGN22530Phase 21 trial
Regeneron · Primary Open Angle Glaucoma (POAG), Ocular Hypertension (OHT)
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.